Swiss contract drug manufacturer Lonza is in talks with a potential buyer for its capsules and health ingredients business, its finance chief said on Wednesday, without naming the other party. “...
Swiss contract drug manufacturer Lonza is in talks with a potential buyer for its capsules and health ingredients business, its finance chief said on Wednesday, without naming the other party. “...
Lonza , the world’s largest contract drug manufacturer, on Wednesday set 2026 targets for its contract development and manufacturing organization (CDMO) business, expecting slower sales growth o...
Swiss contract drug manufacturer Lonza confirmed its full-year guidance on Thursday after a strong third quarter for its main contract development and manufacturing organization (CDMO) business. Oct 2...
